Navigation Links
Antidepressant Eases Anxiety in Older Adults
Date:1/20/2009

Other SSRIs would probably be equally effective, researchers report

TUESDAY, Jan. 20 (HealthDay News) -- Older adults with generalized anxiety disorder treated with the antidepressant Lexapro showed significant improvement in symptoms, a new study reports.

Generalized anxiety disorder is one of the most common psychiatric disorders in older adults. Its symptoms include chronic worry and anxiety and other problems, such as muscle tension, sleep disturbance and fatigue.

"This was the first large-scale study of antidepressant medications as a treatment for anxiety disorders in older adults," said lead researcher Dr. Eric J. Lenze, an associate professor of psychiatry at Washington University School of Medicine in St. Louis.

As many as 7.3 percent of older people suffer from anxiety, and the percent is even higher among those receiving medical care, Lenze said. People with general anxiety can spend up to 40 hours a week consumed by worry, he added.

For many years, the treatment for anxiety in older adults has been either no treatment or such sedatives as Valium (diazepam) or Xanax (alprazolam), Lenze said. "There have been concerns about the safety of these medications in older adults," he added.

Lexapro (escitalopram) is in a class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs), which are thought to be safer, Lenze said. These drugs are approved for treating anxiety, he noted.

Although the researchers used Lexapro for this study, Lenze believes that other SSRIs would produce the same beneficial effect.

For the study, Lenze's team tested the effectiveness of Lexapro in 177 adults 60 and older suffering from general anxiety disorder. The participants were randomly assigned to Lexapro or a placebo for 12 weeks.

The result: 69 percent of people taking Lexapro saw reductions in their anxiety levels, compared with 51 percent of those taking a placebo. Those on Lexapro also had greater improvement in functioning, activity and social functioning, the study found.

The researchers also found that people with high blood pressure taking Lexapro had a significant decrease in blood pressure. "This may suggest some additional health-related benefits of getting treatment for anxiety in this age group," Lenze said, adding, "There are effective treatments for anxiety in older adults other than sedatives."

The study results were published in the Jan. 21 issue of the Journal of the American Medical Association.

Lenze said he hopes this study will help raise awareness that anxiety disorders are common among older people, and are often undetected or treated only with sedatives.

Douglas Mennin, an assistant professor of psychology at Yale University, agrees that physicians should be alert to anxiety problems among their older patients.

"Older adults should certainly be asked about their anxiety," Mennin said. "Many older adults are faced with increasingly stressful situations, such as loss of friends, mobility and job, and anxiety is a natural result," he said.

More information

For more information on anxiety, visit the U.S. National Institute of Mental Health.



SOURCES: Eric J. Lenze, M.D., associate professor of psychiatry, Washington University School of Medicine, St. Louis; Douglas Mennin, Ph.D., assistant professor of psychology, Yale University, New Haven, Conn.; Jan. 21, 2009, Journal of the American Medical Association


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Certain Antidepressants Ease Fibromyalgia Symptoms
2. Pregnancy study finds strong association between two antidepressants and heart anomalies
3. Mylan Receives Final FDA Approval for the Generic Version of the Antidepressant Sarafem(R) Pulvules(R) Capsules
4. 2nd Generation Antidepressants Prove Effective
5. Response rates to antidepressants differ among English- and Spanish-speaking Hispanics
6. Lyriana Announces Antidepressants Now Linked to Declining Libido in Women
7. Antidepressant Scripts Up 16 Million Over 3-Year Period
8. Gene Variations May Predict Antidepressant Response
9. New study replicates association between genetic variation and antidepressant treatment response
10. Do Antidepressants Make Bones Brittle?
11. Antidepressants in suicide prevention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... Georgia (PRWEB) , ... June 24, 2016 , ... ... awards today at the Clinical Decision Making in Emergency Medicine conference in Ponte ... have authored journal articles published in Emergency Medicine Practice and Pediatric ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative ... has initiated cultivation and processing operations at its production facility, and opened its ... Puradigm is the manufacturer of a complete system of proactive air and surface ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016 According to a ... (Standard Pen Needles, Safety Pen Needles), Needle Length (4mm, ... Hormone), Mode of Purchase (Retail, Non-Retail) - Trends & ... studies the market for the forecast period of 2016 ... 2.81 Billion by 2021 from USD 1.65 Billion in ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 23, 2016 Any dentist who has made an ... current process. Many of them do not even offer this ... and high laboratory costs involved. And those who ARE able ... such a high cost that the majority of today,s patients ... Parsa Zadeh , founder of Dental Evolutions Inc. and ...
Breaking Medicine Technology: